It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Most studies on the skin focus primarily on the hair follicle and interfollicular epidermis, whereas little is known regarding the homeostasis of the sebaceous gland (SG). The SG has been proposed to be replenished by different pools of hair follicle stem cells and cells that resides in the SG base, marked by Blimp1. Here, we demonstrate that single Blimp1+ cells isolated from mice have the potential to generate SG organoids in vitro. Mimicking SG homeostasis, the outer layer of these organoids is composed of proliferating cells that migrate inward, undergo terminal differentiation and generating lipid-filled sebocytes. Performing confocal microscopy and mass-spectrometry, we report that these organoids exhibit known markers and a lipidomic profile similar to SGs in vivo. Furthermore, we identify a role for c-Myc in sebocyte proliferation and differentiation, and determine that SG organoids can serve as a platform for studying initial stages of acne vulgaris, making this a useful platform to identify potential therapeutic targets.
The sebaceous gland (SG) has been proposed to be replenished by pools of cells, including a population in the SG base, marked by Blimp1. Here, the authors show that Blimp1+ cells can establish an organoid model of the SG, which is regulated by c-Myc and can recapitulate the early stages of acne vulgaris.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Technion Israel Institute of Technology, Laboratory of Stem Cell Biology and Regenerative Medicine, Department of Biology, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151); Technion Israel Institute of Technology, Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151); Technion Israel Institute of Technology, Technion Integrated Cancer Center, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151)
2 Technion Israel Institute of Technology, Lorry Lokey Interdisciplinary Center for Life Sciences & Engineering, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151); Technion Israel Institute of Technology, Department of Computer Science, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000000121102151)